Petmed Express (PETS) Stock
Online pet pharmacy selling prescription medications and care products. Here's the price, business snapshot, and what's worth knowing about Petmed Express in September 2026.
PetMed Express, trading as PETS, is a small-cap online pet pharmacy that sells prescription and over-the-counter medications, nutritional supplements and pet care products primarily in the US. The business operates an e-commerce platform and direct-to-consumer fulfilment, leveraging brand recognition built around the 1-800-PetMeds name. Investors should note the company’s modest market capitalisation (about $55.7m), which can mean lower liquidity and higher share price volatility compared with larger peers. Revenue drivers include repeat prescriptions and private-label products, while margins depend on sourcing, shipping costs and competitive pricing. Key risks include regulatory oversight of veterinary medicines, competition from larger retail and online players, and concentration of sales channels. For those considering PETS, view it as speculative and research operational performance, cash flow and regulatory developments carefully. This information is general and educational only, not personalised investment advice; values can fall as well as rise, so assess suitability for your circumstances.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying PetMed Express stock with a target price of $4.22, indicating growth potential.
Financial Health
PetMed Express is generating decent revenue and cash flow, but profit margins are somewhat low.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Online Pharmacy Focus
Direct-to-consumer e-commerce and repeat prescriptions can support steady demand, though sales can fluctuate with competition and regulation.
Niche Market Position
A recognised brand in the pet pharmacy niche may help retention, but larger retailers and marketplaces pose competitive pressure.
Regulatory & Risks
Veterinary drug regulation and supply-chain costs are material factors; the small market cap also means higher volatility and liquidity risk.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
